These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12739338)

  • 1. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in cancer of the upper aerodigestive tract].
    Bourguet P;
    Bull Cancer; 2003 Feb; 90 Spec No():S67-79. PubMed ID: 12739338
    [No Abstract]   [Full Text] [Related]  

  • 2. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in skin and ocular melanoma].
    Bourguet P;
    Bull Cancer; 2003 Feb; 90 Spec No():S42-6. PubMed ID: 12739335
    [No Abstract]   [Full Text] [Related]  

  • 3. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in cancer of the thyroid].
    Bourguet P;
    Bull Cancer; 2003 Feb; 90 Spec No():S105-9. PubMed ID: 12739343
    [No Abstract]   [Full Text] [Related]  

  • 4. Esophageal cancer and head and neck cancer.
    Lowe VJ; Stack BC
    Semin Roentgenol; 2002 Apr; 37(2):140-50. PubMed ID: 12134367
    [No Abstract]   [Full Text] [Related]  

  • 5. PET in face and neck tumours.
    Rankin SC
    Cancer Imaging; 2006 Oct; 6(Spec No A):S89-95. PubMed ID: 17114083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in sarcomas].
    Bourguet P;
    Bull Cancer; 2003 Feb; 90 Spec No():S96-102. PubMed ID: 12739341
    [No Abstract]   [Full Text] [Related]  

  • 7. Investigation of thyroid, head, and neck cancers with PET.
    Zhuang H; Kumar R; Mandel S; Alavi A
    Radiol Clin North Am; 2004 Nov; 42(6):1101-11, viii. PubMed ID: 15488560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in digestive system neoplasms].
    Bourguet P;
    Bull Cancer; 2003 Feb; 90 Spec No():S56-66. PubMed ID: 12739337
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of PET FDG in the management of head and neck squamous cell cancer.
    Wong WL; Saunders M
    Clin Oncol (R Coll Radiol); 1998; 10(6):361-6. PubMed ID: 9890536
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of (18)F-FDG, (131)I-Na, and (201)Tl in diagnosis of recurrent or metastatic thyroid carcinoma.
    Shiga T; Tsukamoto E; Nakada K; Morita K; Kato T; Mabuchi M; Yoshinaga K; Katoh C; Kuge Y; Tamaki N
    J Nucl Med; 2001 Mar; 42(3):414-9. PubMed ID: 11337516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Technical bases and regulatory principles].
    Bourguet P;
    Bull Cancer; 2003 Feb; 90 Spec No():S18-22. PubMed ID: 12739333
    [No Abstract]   [Full Text] [Related]  

  • 12. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in urological cancers].
    Bourguet P;
    Bull Cancer; 2003 Feb; 90 Spec No():S80-7. PubMed ID: 12739339
    [No Abstract]   [Full Text] [Related]  

  • 13. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in bronchopulmonary and pleural cancers].
    Bourguet P;
    Bull Cancer; 2003 Feb; 90 Spec No():S23-41. PubMed ID: 12739334
    [No Abstract]   [Full Text] [Related]  

  • 14. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in unknown primary neoplasms].
    Bourguet P;
    Bull Cancer; 2003 Feb; 90 Spec No():S103-4. PubMed ID: 12739342
    [No Abstract]   [Full Text] [Related]  

  • 15. [Positron emission tomography in head and neck oncology: five cases].
    Courtois A; Foehrenbach H; Maszelin P; De Dreuille O; Garcia D; Kossowski M; Merlet P; Gaillard JF; Poncet JL
    Ann Otolaryngol Chir Cervicofac; 2001 Sep; 118(4):254-60. PubMed ID: 11679846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG-PET in head and neck, and thyroid cancer.
    Macapinlac HA
    Chang Gung Med J; 2005 May; 28(5):284-95. PubMed ID: 16086543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological uptake of [18F]fluorodeoxyglucose in the neck and upper chest region: are there predictive characteristics?
    Sturkenboom MG; Franssen EJ; Berkhof J; Hoekstra OS
    Nucl Med Commun; 2004 Nov; 25(11):1109-11. PubMed ID: 15577589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The promise FDG in diagnosis and surveillance of head and neck cancer.
    Mancuso AA; Drane WE; Mukherji SK
    Cancer; 1994 Aug; 74(4):1193-5. PubMed ID: 8055436
    [No Abstract]   [Full Text] [Related]  

  • 19. Current status of FDG-PET for head and neck cancer.
    Wong RJ
    J Surg Oncol; 2008 Jun; 97(8):649-52. PubMed ID: 18493944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of 18FFDG PET/CT in the treatment of head and neck cancers: posttherapy evaluation and pitfalls.
    Kapoor V; Fukui MB; McCook BM
    AJR Am J Roentgenol; 2005 Feb; 184(2):589-97. PubMed ID: 15671385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.